Detecting disease
Published 11/3/2023The Animal Infection and Monitoring Services core supports studies on a wide variety of bacterial and viral diseases.
Trailblazing treatments
Published 11/3/2023Teresa Lever is developing tools to objectively diagnose and treat swallowing impairments associated with neurological diseases, cancer, genetic disorders and aging.
Ongoing vaccine projects address 100-year-old disease and others in fight against tick-borne diseases
Published 10/11/2023Ongoing vaccine projects address 100-year-old disease and others in fight against tick-borne diseases.
Chris Lorson on fast track for spinal muscular atrophy drug
Published 10/9/2023Curators’ Distinguished Professor Chris Lorson is forging a new path at the University of Missouri for drug development and clinical trials using a $4.3 million National Institutes of Health (NIH) Blueprint for Neuroscience Research grant.
$12 Million Grant Will Boost Workforce Development at MU’s Laboratory for Infectious Disease Research
Published 8/21/2023NIH-funded grant will provide additional trainings and support to existing University of Missouri employees, as well as recruit new employees.
Longhorned Ticks Discovered in Boone County for First Time, MU Researchers Find
Published 7/25/2023Researchers at the University of Missouri College of Veterinary Medicine have recently discovered invasive longhorned ticks in Boone County, Missouri, for the first time.
CVM Innovations in 2022
Published 6/22/2023MU College of Veterinary Medicine researchers made discoveries and generated innovations in myriad areas in 2022 thanks in part to a unique combination of resources and disciplines at Missouri’s largest public research university.
Picking Awarded $3.8 Million Grant by NIAID
Published 3/03/2023Wendy Picking, PhD, a professor of veterinary pathobiology at the University of Missouri College of Veterinary Medicine and a recent Mizzou Forward hire, recently secured a $3.8 million grant from the National Institute of Allergy and Infectious Diseases. The grant will fund development of a vaccine to prevent colonization of Pseudomonas aeruginosa, a hospital-acquired infection that occurs after intubation or catheterization.